Get started
Author

Bshra Ali A. Alsfouk

Observed names: Alsfouk, Bshra, Alsfouk, Bshra A, Alsfouk, Bshra A., B A Alsfouk, Bshra A Alsfouk, Bshra A. Alsfouk
ORCID: 0000-0001-6489-6035
Observed ORCID: 0000-0001-6489-6035
OpenAlex ID: A5028807146
Design, Synthesis, Docking, DFT, MD Simulation Studies of a New Nicotinamide-Based Derivative: In Vitro Anticancer and VEGFR-2 Inhibitory Effects
2022 · Eslam B. Elkaeed, Reda G. Yousef, et al. · Molecules · 121
PDF
Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy
2020 · Bshra Ali A. Alsfouk, Martin J. Brodie, et al. · JAMA Neurology · 84
PDF
New quinoline and isatin derivatives as apoptotic VEGFR-2 inhibitors: design, synthesis, anti-proliferative activity, docking, ADMET, toxicity, and MD simulation studies
2022 · Eslam B. Elkaeed, Mohammed S. Taghour, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 75
Discovery of New VEGFR-2 Inhibitors: Design, Synthesis, Anti-Proliferative Evaluation, Docking, and MD Simulation Studies
2022 · Eslam B. Elkaeed, Reda G. Yousef, et al. · Molecules · 56
PDF
Discovery of new quinoline and isatine derivatives as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative, docking and MD simulation studies
2023 · Mohammed S. Taghour, Hazem Elkady, et al. · Journal of Biomolecular Structure and Dynamics · 49
Ligand and Structure-Based In Silico Determination of the Most Promising SARS-CoV-2 nsp16-nsp10 2′-o-Methyltransferase Complex Inhibitors among 3009 FDA Approved Drugs
2022 · Ibrahim H. Eissa, Mohamed S. Alesawy, et al. · Molecules · 49
PDF
Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathway
2022 · Mohammed S. Taghour, Hazem Elkady, et al. · PLoS ONE · 48
PDF
Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studies
2022 · Reda G. Yousef, Alaa Elwan, et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 48
Distance Education During COVID-19 Pandemic: A College of Pharmacy Experience
2021 · Najla Altwaijry, Alnada Ibrahim, et al. · Risk Management and Healthcare Policy · 48
PDF
New theobromine derivative as apoptotic anti-triple-negative breast cancer targeting EGFR protein: CADD story
2023 · Ibrahim H. Eissa, Reda G. Yousef, et al. · Journal of Molecular Structure · 47
In silico, in vitro VEGFR-2 inhibition, and anticancer activity of a 3-(hydrazonomethyl)naphthalene-2-ol derivative
2022 · Eslam B. Elkaeed, Reda G. Yousef, et al. · Journal of Biomolecular Structure and Dynamics · 45
Multi-Phase In Silico Discovery of Potential SARS-CoV-2 RNA-Dependent RNA Polymerase Inhibitors among 3009 Clinical and FDA-Approved Related Drugs
2022 · Eslam B. Elkaeed, Hazem Elkady, et al. · Processes · 41
PDF
Rationale design and synthesis of new apoptotic thiadiazole derivatives targeting VEGFR-2: computational and in vitro studies
2023 · Walid E. Elgammal, Hazem Elkady, et al. · RSC Advances · 32
PDF
The Computational Preventive Potential of the Rare Flavonoid, Patuletin, Isolated from Tagetes patula, against SARS-CoV-2
2022 · Ahmed M. Metwaly, Eslam B. Elkaeed, et al. · Plants · 32
PDF
New Theobromine Derivatives Inhibiting VEGFR-2: Design, Synthesis, Antiproliferative, Docking and Molecular Dynamics Simulations
2023 · Hazem A Mahdy, Hazem Elkady, et al. · Future Medicinal Chemistry · 30
A New Anticancer Semisynthetic Theobromine Derivative Targeting EGFR Protein: CADDD Study
2023 · Ibrahim H. Eissa, Reda G. Yousef, et al. · Life · 28
PDF
Characteristics and treatment outcomes of newly diagnosed epilepsy in older people: A 30‐year longitudinal cohort study
2020 · Bshra Ali A. Alsfouk, Haris Hakeem, et al. · Epilepsia · 27
Jusanin, a New Flavonoid from Artemisia commutata with an In Silico Inhibitory Potential against the SARS-CoV-2 Main Protease
2022 · Yerlan M. Suleimen, Rani A. Jose, et al. · Molecules · 25
PDF
Synthesis, biological evaluation and computer-aided discovery of new thiazolidine-2,4-dione derivatives as potential antitumor VEGFR-2 inhibitors
2023 · Hazem Elkady, Osama A. El-Dardir, et al. · RSC Advances · 23
PDF
Design, Synthesis, In Silico and In Vitro Studies of New Immunomodulatory Anticancer Nicotinamide Derivatives Targeting VEGFR-2
2022 · Reda G. Yousef, Wagdy M. Eldehna, et al. · Molecules · 23
PDF
Preparation and Characterization of Patuletin-Loaded Chitosan Nanoparticles with Improved Selectivity and Safety Profiles for Anticancer Applications
2023 · Ahmed M. Metwaly, Ahmed M. Abdel-Raoof, et al. · Journal of Chemistry · 21
PDF
Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30‐year cohort study
2019 · Bshra A. Alsfouk, Aisha A. Alsfouk, et al. · Epilepsia · 19
Anti-virulence potential of patuletin, a natural flavone, against Staphylococcus aureus: In vitro and In silico investigations
2024 · Ahmed M. Metwaly, Moustafa M. Saleh, et al. · Heliyon · 18
Isolation and In Silico Inhibitory Potential against SARS-CoV-2 RNA Polymerase of the Rare Kaempferol 3-O-(6″-O-acetyl)-Glucoside from Calligonum tetrapterum
2022 · Yerlan M. Suleimen, Rani A. Jose, et al. · Plants · 18
PDF
Anti-breast cancer potential of a new xanthine derivative: In silico, antiproliferative, selectivity, VEGFR-2 inhibition, apoptosis induction and migration inhibition studies
2023 · Ibrahim H. Eissa, Reda G. Yousef, et al. · Pathology - Research and Practice · 17
Works count: 112
Citation count: 1,434
H-index: 21
I10-index: 42
Year
Topic
Type